Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

If you knew that the blueberry muffin you had this morning contained 438 calories, would you have thought twice before choosing it to go with your coffee? If calories had been shown on the menu might it have influenced the pizza or pasta you selected for dinner last night?

When Michael Bloomberg was mayor of New York City, he led the way with policies to enforce calorie labelling on menus. Many states followed suit, and this year the labelling will finally become mandatory across the USA for chains with more than 20 outlets. In the UK, around 70% of high street coffee shops, quick-serve restaurants and other chains now label the calorie content of their products too, albeit on a voluntary basis.

It’s easy to support nutritional labelling as a consumer right, to allow people who want this information to make informed choices about what they eat. But it’s been less clear whether labelling actually leads to a reduction in the calories we eat.

Read the full article on The Conversation website, written by Susan Jebb, Nuffield Department of Primary Care Health Sciences, and Theresa Marteau, Director of the Behaviour and Health Research Unit at the University of Cambridge. 

Oxford is a subscribing member of The ConversationFind out how you can write for The Conversation.

Similar stories

Long COVID: vaccination could reduce symptoms, new research suggests

While evidence suggests that people who are vaccinated before they get COVID are less likely to develop long COVID than unvaccinated people, the effectiveness of vaccination on existing long COVID has been less clear.

Com-COV vaccine study to research third dose booster options for 12-to-15-year-olds

Researchers running the University of Oxford-led Com-COV programme have launched a further study of COVID-19 vaccination schedules in young people aged 12 to 15 – with a focus on assessing different options for a third dose booster vaccination.

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.